Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
Soohyung ParkSeung-Woon RhaByoung Geol ChoiJang Hyun ChoSang Ho ParkJin Bae LeeYong Hoon KimSang Min ParkJae Woong ChoiJi Young ParkEun-Seok ShinJae Beom LeeJon SuhJei Keon ChaeYoung Jin ChoiMyung Ho JeongKwang Soo ChaSeung Wook LeeUng KimGi Chang KimWoong-Gil ChoiYun-Hyeong ChoDeok-Kyu ChoJihun AhnSoon-Yong SuhSe Yeon ChoiJae Kyeong ByunJin Ah ChaSoo Jin HyunJi Bak KimCheol Ung ChoiChang Gyu ParkPublished in: American heart journal (2023)
Due to its limited power, no definite conclusion can be drawn regarding complete revascularization strategy from the present study. Further large randomized clinical trials would be warranted to confirm optimal timing of complete revascularization for patients with STEMI and MVD.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- st elevation myocardial infarction
- acute coronary syndrome
- double blind
- phase iii
- phase ii
- open label
- coronary artery bypass
- cardiovascular events
- atrial fibrillation
- clinical trial
- placebo controlled
- study protocol
- cross sectional
- randomized controlled trial
- type diabetes
- heart failure